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Deprescribing medications for older adults in the primary care context: A
mixed studies review
Abstract

Aims:This review investigates the factors that influence deprescribing of medications in primary care from the
perspective of general practitioners (GPs) and community‐living older adults.
Methods:A mixed studies review structure was adopted searching Scopus, CINAHL, PsychINFO, ProQuest,
and PubMed from January 2000 to December 2017. A manual search of reference lists was also conducted.
Studies were included if they were original research available in English and explored general deprescribing
rather than deprescribing of a specific class of medications. The Mixed Methods Assessment Tool was used to
assess the quality of studies, and content analysis generated common categories across studies.
Results:Thirty‐eight articles were included, and 7 key categories were identified. The review found that the
factors that influence deprescribing are similar across and within health systems and mostly act as barriers.
These factors remained unchanged across the review period. The structural organisation of health systems
remains poorly suited to facilitate deprescribing. Individual knowledge gaps of both GPs and older adults
influence practices and attitudes towards deprescribing, and significant communication gaps occur between
GPs and specialists and between GPs and older adults. As a result, deprescribing decision making is
characterised by uncertainty, and deprescribing is often considered only when medication problems have
already arisen. Trust plays a complex role, acting as both a barrier and facilitator of deprescribing.
Conclusions:Deprescribing is influenced by many factors. Despite recent interest, little change has occurred.
Multilevel strategies aimed at reforming aspects of the health system and managing uncertainty at the practice
and individual level, notably reducing knowledge limitations and closing communications gaps, may achieve
change.
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in primary care from the perspective of general practitioners (GPs) and community‐living
older adults.
Methods:

A mixed studies review structure was adopted searching Scopus,

CINAHL, PsychINFO, ProQuest, and PubMed from January 2000 to December
2017. A manual search of reference lists was also conducted. Studies were included
if they were original research available in English and explored general deprescribing
rather than deprescribing of a specific class of medications. The Mixed Methods
Assessment Tool was used to assess the quality of studies, and content analysis
generated common categories across studies.
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Results:

Thirty‐eight articles were included, and 7 key categories were identified.

The review found that the factors that influence deprescribing are similar across and
within health systems and mostly act as barriers. These factors remained unchanged
across the review period. The structural organisation of health systems remains poorly
suited to facilitate deprescribing. Individual knowledge gaps of both GPs and older
adults influence practices and attitudes towards deprescribing, and significant communication gaps occur between GPs and specialists and between GPs and older adults. As
a result, deprescribing decision making is characterised by uncertainty, and deprescribing is often considered only when medication problems have already arisen. Trust
plays a complex role, acting as both a barrier and facilitator of deprescribing.
Conclusions:

Deprescribing is influenced by many factors. Despite recent interest,

little change has occurred. Multilevel strategies aimed at reforming aspects of the
health system and managing uncertainty at the practice and individual level, notably
reducing knowledge limitations and closing communications gaps, may achieve change.
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I N T RO D U CT I O N

specific treatment guidelines in the context of multiple morbidities,
lower treatment thresholds for chronic diseases,3 the ongoing use of

Polypharmacy use in older adult populations is increasing.1,2 A number

preventives,4 and the medicalisation of some of the normal processes

of reasons have been suggested for this, including the use of disease

of aging.5 The use of polypharmacy, commonly identified as taking five
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or more concurrent medications, may be appropriate in some circum-

increasing evidence that is now available on this topic, a review that

stances.6 However, it also places older adults at a potentially higher risk

incorporates all study types is warranted. Interventions to promote

of adverse drug reactions,7 resulting in increased personal and health

deprescribing will require change on the part of both prescribers and

care costs, hospitalisations, poor health outcomes,8 and/or increased

older adults, so it is important to consider how their views interact to

9

mortality rates.

10

This level of risk is considerable

and as such,

create the context where deprescribing discussions can take place.

warrants further attention as a public health11 and ethical issue.12
Medications are rarely indicated for lifelong usage, as many factors may change during the course of treatment.13 This is due, in part,

2

METHODS

|

to the complexity of managing multiple morbidities experienced by
many older adults, the lack of evidence available to inform decisions
14

and changes in health, frailty, and, often, autonomy.

As a result,

A mixed studies review methodology was used as a guide to explore
the factors that influence deprescribing.27,28

older adults and their general practitioners (GPs) face particular chal-

2.1

lenges when deciding on the most appropriate treatment regimens.
Deprescribing has been suggested as one intervention to reduce
inappropriate polypharmacy.7 The term deprescribing was first used
by Woodward15 and is defined as a systematic process supervised
by a medical professional to reduce or discontinue long‐term medications.16 Deprescribing is indicated where the existing or potential
harms outweigh existing or potential benefits of a particular medication/medications. Deprescribing may be relevant at any point in the
life course, although it is most often considered in the context of medication use for older adults who, as a group, are growing exponentially
worldwide.17 Ideally, the process of deprescribing takes into account

Eligibility criteria

|

2.1.1

Inclusion criteria

|

Full text primary research articles were included that were available in
English, published between January 2000 and December 2017, and
that investigated deprescribing or medication cessation/discontinuation in the primary care context for older adults, living independently
in the community. General deprescribing was targeted. Articles were
also included where deprescribing was mentioned as a mechanism to
reduce polypharmacy or potentially inappropriate medications or in
the context of the management of multiple morbidities.

changes in the context of an individual's treatment goals, their current
level of functioning, life expectancy, values, and preferences.18 How-

2.1.2

Exclusion criteria

|

7

Deprescribing of specific medications or medication classes were not

This is despite evidence of the usefulness of deprescribing to address

included, as unique factors related to individual medication use, such

polypharmacy and reduce mortality,19 and an increased awareness of

as specific withdrawal issues, might have influenced deprescribing

ever, it is not a process that is routinely considered in primary care.

deprescribing at both international

20

practices and attitudes in these instances. Articles discussing

6,21,22

and at national levels.

Three previous literature reviews in this research area are avail-

deprescribing within long‐term residential aged care facilities were

23-25

One examined the barriers and facilitators of deprescribing

excluded, as the nature of such care changes the relationship between

from the perspective of patients, using a narrative synthesis of qualita-

primary care providers and older adults, limiting the ability of older

able.

25

tive, quantitative, and mixed methods studies.

23

Anderson et al,

on

adults

to

act

autonomously.29

Similarly,

articles

discussing

the other hand, sought to understand barriers and facilitators from

deprescribing within acute care hospital settings were excluded, as it

the perspective of the prescriber, conducting a synthesis of qualitative

is less likely that there is an established, ongoing relationship between

studies. These initial reviews by Reeve et al25 and Anderson et al23

the prescriber and older adult in these settings. Articles were also

were conducted just as interest in this research area gained momentum

excluded if they only related to discontinuing medications during palli-

26

with most papers being published

since 2015. As such, they were

exploratory and broad in scope, being conducted across all health care

ative stages of care, as the context of medication deprescribing is markedly different in these scenarios.30

settings, targeting deprescribing in the context of all adult aged patient
groups, and included both general deprescribing and deprescribing of

2.2

|

Literature search

single medication types. A further ethnographic review by Bokhof and
Junius‐Walker24 had a narrower focus, synthesising findings from qual-

An initial scoping search was conducted in August 2016; however,

itative research, to investigate the management of and attitudes

due to the rapid proliferation of research in this area, a further search

towards reducing polypharmacy (including deprescribing), from the per-

of the following 5 databases was conducted in November 2017:

spective of both community‐living older adults and GPs. This is impor-

CINAHL, PsychINFO, ProQuest, PubMed, and Scopus. The results

tant because, as mentioned earlier, deprescribing is most often

are shown in Figure 1.

considered in the context of the treatment of older adults.
The purpose of the current review is to build on Bokhof and Junius‐

The search was conducted using combinations of the following
search terms and the Boolean operator “AND.”

Walker24 work by investigating the factors that influence deprescribing
from the perspective of both GPs and adults aged 65 years or older.

• “older adult” OR senior* OR elder*

Independent, community‐living older adults are the focus of this

• “general practice” OR “general practitioner” OR GP OR “family

review, as the majority of this group retain autonomy and are capable

physician” OR physician OR “primary care” OR doctor OR clinician

of being responsible for their own health decisions,17 hence the impor-

OR prescriber OR “health professional” OR “health care

tance of considering deprescribing from their perspective. Given the

professional”

GILLESPIE
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PRISMA flow chart of study

• deprescribe* OR discontin* OR cessation OR cease OR
withdraw*OR stop* OR reduc* OR optim*
• polypharmacy OR medication OR medicines OR prescribing OR

when studies with a range of methodological techniques need to be
assessed. The first 2 authors screened the studies to determine their
quality rating, applying the scoring system described in Pluye et al,32
and scores were confirmed by the third author.

“prescription drug”
An example search strategy is detailed in Appendix S1.
Search terms were applied to abstracts, keywords, and titles. In

2.5

|

Analytic approach

addition, a secondary search of reference lists of relevant articles

The findings sections of included studies were analysed using content

was conducted, to check for other potentially eligible articles. The

analysis.33 Findings were explored across all articles to identify factors

search was conducted by the main author, following refinement of

influencing deprescribing. The first author became familiar with the

the search terms under the guidance of a university librarian.

content by reading each study multiple times. Unique codes were
identified and tabled. The relationship between codes was considered

2.3

|

Identifying and selecting relevant articles

After duplicate citations were removed, one reviewer (RG) screened

in order to organise the codes into groups. These groupings were
discussed by all researchers in order to refine the final categories.
Seven key categories were generated from the data.

titles for relevant articles. Abstracts and/or full texts were reviewed if
the article met the inclusion criteria. Key data from potential articles
were extracted into a table. This was reviewed by all authors to confirm

3

|

RESULTS

the relevance and appropriateness of each article. As the focus of the
review was on autonomous community‐living adults, any articles that

Searches of electronic databases and the reference lists of related articles

included community‐living older adults with cognitive impairment were

identified 4604 potentially relevant articles. Following the application of

excluded.

the exclusion and inclusion criteria, 38 articles remained and were
reviewed (Figure 1). Table 1 summarises the data from the included

2.4

|

Quality assessment of included articles

The quality of the included articles was assessed using the Mixed
31

Methods Appraisal Tool (MMAT).

This checklist is suited for use

studies. The studies were conducted across a number of countries with
varied health systems. Only 2 studies included the perspectives of both
GPs and medication users.61,68 Thirteen studies included only older adult
participants. The remainder included GPs (family physicians) (n = 16) or a

Belgium

New
Zealand

Norway

UK

Ireland

Ireland

Ireland

USA

Canada

Canada

USA

USA

Bagge et al36 2013

Bell et al.37 2015

Cantrill et al38 2000

Clyne et al39 2013

Clyne et al40 2016

Clyne et al41 2017

Elliot et al42 2007

Farrell et al43 2015

Farrell et al44 2018

Fried et al45 2008

Fried et al46 2011

2007 Australia

Country

Anthierens et al35
2010

Anderson et al

34

Sample Size
Health Care
Providers

17 GPs

5 GPs

22 GPs

13 GPs

N/A

To understand primary care clinicians treatment
decision‐making processes for older patients with
multiple diseases

To explore what older adults with multimorbidity value
when deciding their medication treatment
preferences.

To determine if the use of deprescribing guidelines
would change prescriber's perception of self‐efficacy
and enable deprescribing

To identify medication classes where evidence based
deprescribing guidelines would be most useful

To understand how older adults taking multiple
medications make decision.

40 participants:
(36 GPs
2 NP
1 physician assistant
1 pharmacist)

N/A

50 (38 GPs) participants
giving 79 responses
across 4 survey rounds

65 participants (round 1)
(8 geriatricians
35 pharmacists
11 GPs
10 nurse practitioners)
n = 47 in round 3

N/A

N/A
To explore influences and the beliefs and attitudes
toward medications of community‐living, older adults'
with polypharmacy.

To explore GP views on prescribing of potentially
inappropriate medications in older adults

To test the acceptance by GPs of a proposed
intervention to reduce potentially inappropriate
prescribing in older adults

To explore factors that influence prescribers in general
practice to continue inappropriate long‐term
medications

To explore the factors that might influence prescribers
to deprescribe falls‐risk‐increasing drugs

To explore the attitudes of older adults age 75 or older
towards their medicines

65 GPs
To describe GPs' perspective and beliefs about
polypharmacy. Identify the role of the GP in improving
prescribing

To explore the views of GPs and consultant pharmacists 32 GPs
regarding inappropriate polypharmacy and
15 consultant pharmacists
(CPs)
deprescribing in primary care

Research Aim/s

Summary of research articles included in the review

Author/Year

TABLE 1

N/A

66

N/A

N/A

20

196

N/A

N/A

N/A

N/A

60

N/A

N/A

Older
Adults

Focus groups

Focus groups

Questionnaire

Modified Delphi approach

Semistructured interviews

Secondary analysis of
cluster randomised
control trial data
Questionnaire and semi
structured interviews

Interviews

Focus group followed by
semistructured
interviews

Semistructured interviews

Focus groups.

Semistructured interviews

Semistructured interviews

Focus groups

Data Collection
Methods

Content analysis

Grounded theory
approach using
constant comparative
method

Descriptive statistics,
longitudinal analysis

Content analysis and
significance testing

Constant comparison

Multiple regression and
thematic analysis

Thematic analysis

Thematic analysis

Thematic analysis

Systematic text
condensation

Thematic analysis

Content analysis

Thematic analysis

Data Analysis

&C?JRFѥ1AGCLACѥ0CNMPRQ
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75

75

25

Not
scored

75

75

100

75

50

100

75

75

100

MMAT
Appraisal
Scores, %

4 of 13
ET AL.

USA

USA

USA

Netherlands To explore GPs main aims in the management of multiple 25 GPs
morbidity and what influences management in daily
practice

Australia

Sweden

Sweden

Singapore

Australia

Australia

Ireland

Linsky et al51 2017

Linsky et al52 2017

Luijks et al53 2012

Magin et al54 2015

Moen et al55 2009

Moen et al56 2010

Ng et al57 2017

Reeve et al58 2013

Reeve et al59 2016

Riordan et al60 2017

304 GPs
68 NP or physician
assistants
39 CPs

20 prescriber participants
11 GPs
3 NPs
6 pharmacists

22 GPs

N/A

N/A

To identify the determinants of GP prescribing for older 16 GPs
adults and to explore their views on intervention
strategies

To explore the beliefs and attitudes of older adults and
informal carers toward deprescribing

Explore differences in attitudes, beliefs, and previous
experiences regarding polypharmacy and stopping
current medications

To identify patients accepting of deprescribing and their N/A
attitudes to deprescribing

31 GPs

N/A

14 older adults
14 informal
carers

100

136

N/A

59

N/A

N/A

803 US Veterans

N/A

N/A

27

N/A

N/A

Older
Adults

Not
scored

MMAT
Appraisal
Scores, %

Directed content analysis
and conventional
content analysis.

Descriptive statistical
analysis, confidence
intervals

Descriptive statistical
analysis

Content analysis

Content analysis

Thematic analysis

Constant comparative
analysis

Bivariate analysis of
association logistic
regression

Descriptive statistics

Thematic analysis
informed by grounded
theory

&C?JRFѥ1AGCLACѥ0CNMPRQ
(Continues)

100

100

75

75

75

75

75

100

75

75

75

Modified grounded theory 75
approach

Descriptive statistics and 75
univariable and
multivariable regression

Analysis of Likert scale
responses

Data Analysis

Semistructured interviews. Content analysis using
framework approach

Focus groups

Questionnaire

Questionnaire

Focus groups

Focus groups

Semistructured interviews

Focus groups

Questionnaire

Questionnaire

Semistructured interviews

Semistructured interviews
and focus groups

Questionnaire and health
record review

Modified Delphi approach

Data Collection
Methods

ET AL.

To understand GP's perspective of treating older adult
users of multiple medicines

To describe multiple medicine use from the perspective N/A
of the older adul.

Explore GPs' potentially inappropriate prescribing in
community dwelling older adults

To determine the characteristics of patients who are
N/A
more or less likely to report discontinuing medications

To conduct a national survey of primary care providers
to identify preferences for interventions to enhance
their capability to deprescribe

To understand the attitudes and beliefs of prescribers
towards polypharmacy and medication deprescribing

N/A

Linsky et al50 2015

To identify patient perspectives on intentional
discontinuation of prescription medications

USA

61 GPs
2103 health records
analysed

9 representatives of the
disciplines of nursing,
medicine and pharmacy
n = 8 completed rounds 2
and 3

Linsky et al49 2015

To investigate variability in prescribing especially of
potentially inappropriate prescribing.

To develop strategies for identifying and addressing
problems with medication regimens for older adults
with multiple medical conditions

Research Aim/s

USA

USA

Country

Sample Size
Health Care
Providers

Ie et al48 2017

Fried et al

47

2016

(Continued)

Author/Year

TABLE 1

GILLESPIE
5 of 13

Canada

Ireland

Nordic
countries

Sirois et al65 2016

Smith et al66 2010

Sondergaard et al67
2015

To determine awareness of medication harm and
familiarity with the term deprescribing among older
community‐living adults.

Canada

New
Zealand

Australia

Turner et al69 2017

Wallis et al70 2017

Weir et al71 2017

N/A

N/A

6

Older
Adults

24 GPs

N/A

272 GPs

76 GPs completed
questionnaires

180 GPs

13 GPs
7 pharmacists

N/A

Content analysis

Thematic analysis

Content analysis using
framework approach

Data Analysis

Semistructured interviews

Questionnaire

Questionnaires paired
prescriber and patient

Recorded workshop
discussions and open
response questionnaire

Focus groups

Questionnaire

75

75

100

75

75

75

50

75

75

75

75

MMAT
Appraisal
Scores, %

Abbreviations: ADEs, adverse drug reactions; CP, consultant pharmacists; EBM, evidence‐based medicine; GPs, general practitioners (this includes primary care family physicians); N/A, not applicable; NP, nurse practitioners; QoL, quality of life

Phenomenological
approach

Multistage coding based
on grounded theory

Descriptive statistics and
regression analysis

Kappa statistics

Framework analysis

Content analysis

Descriptive statistics

Semi structured interviews Grounded theory
approach

Focus groups

Focus groups

Semi‐structured
interviews

Data Collection
Methods

30 older adults
Semistructured interviews
15 companions

N/A

2665

272

N/A

N/A

129

20 GPs
N/A
Median age of patient cases
selected: 75 y

N/A
To explore the reasons behind the variation in patient
preferences, attitudes, and experiences in the context
of deprescribing

To explore the barriers and facilitators to deprescribing
as reported by primary care physicians in everyday
practice

To understand the level of patient and prescriber
agreement when medication/s have been
discontinued

Straand and Sandvik68 Norway
2001

To explore GPs' views and attitudes towards problems
and challenges related to the treatment of patients
with multimorbidity

To document the views and beliefs of GPs and
pharmacists on managing multiple morbidity
in primary care.

To describe community‐dwelling older individuals'
attitudes and perceptions towards deprescribing

To explore how and why GPs make decisions when
prescribing for multimorbid patients

Ireland

Sinnott et al64 2015

12 GPs

Netherlands To explore strategies GPs use when optimising
medication regimens for older adults with
polypharmacy

1 GP
1 GP trainee
1 medical student

Sinnige et al63 2016

To identify the perceptions of older adults and GPs
regarding communication about polypharmacy and
medication safety

Research Aim/s

Netherlands To explore the feelings of experienced GPs regarding
29 GP participants
deprescribing and their involvement of older patients
in decision making

Germany

Country

Sample Size
Health Care
Providers

Schuling et al62 2012

Schopf et al

61

2017

(Continued)

Author/Year

TABLE 1
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mix of primary care prescribers including GPs, nurse practitioners, GPs'

to facilitate deprescribing. Familiarity allowed GPs to build trust and

assistants, consulting pharmacists, and geriatricians (n = 7).

gain an overview of their older patients' preferences, health concerns,

The majority of the studies (n = 28) used qualitative methods,

and medications.35,50,53,70 General practitioners generally felt that this

eg, focus groups, semistructured interviews, and Delphi approach;

positioned them as the gatekeepers or coordinators of their older

41

patients' care.53,60,66,67 However, this perception was contradicted

one

used

methods.

mixed

methods,

and

9

used

quantitative

44,48,51,52,57,58,65,68,69

by another recurrent dialogue where GPs noted that the hierarchy
between themselves and their specialist counterparts prevented them

3.1

from questioning medication prescribing decisions, even if it meant

Quality of the included studies

|

continuing medications with no clear indications or that were poten-

The quality of the included studies varied (see Table 1). All but one
44

study

tially inappropriate.35,38,40,46,50,54,56,62,63

reached 50% or more in the MMAT appraisal score. The 2

Both older adults and their GPs thought that there was not

researchers who applied the MMAT came to a consensus, prior to

enough time during consultations to review medications, consider

the use of the tool, on the meaning of the criteria applied to the

patient preferences, and determine the priorities patients val-

qualitative studies. This is recommended by the MMAT developers.31

ued.34,37-39,48,50,53,55,56,60,61,63,64,66,70 Furthermore, GPs were not ade-

This may mean that we applied the tool differently than others. Few

quately reimbursed for more complex consultations, especially with

qualitative studies included researcher reflexivity as required by the

patients with multiple morbidities,53,67 including undertaking medica-

MMAT. Response rates for the quantitative surveys of GPs were

tion reviews, and deprescribing discussions and follow‐up.34,35,46,56

generally low, with no study reaching the required MMAT response

Some GPs avoided addressing complex issues because of their aware-

rate (≥60%). However, it should be noted that a low response rate

ness of the lack of time.60,66

72

is typical when surveying this population

and that the responses

Access to support alongside or within individual practice organisa-

were adequate to address the descriptive, exploratory aims of the

tions may influence deprescribing. Changes in practice were suggested,

studies. The 2 studies that used a modified Delphi technique were

including the ability to consult with pharmacists,50,51,60,62,63 inviting fel-

not scored, as the criteria used in the tool were found to be not

low GPs to conduct independent prescribing reviews,38 phone consults

applicable.

with geriatricians and/or specialists,66 and referrals to services able to
provide nonpharmacological options.70 However, it is notable that the

3.2

GPs in the study by Sinnige et al63 only sought help when their patient's

Findings

|

condition did not improve. The use of information technology applicaSeven key categories were identified that influence deprescribing.

tions designed to monitor and support prescribing was met with some

These were the health care system, older adult and GP characteristics,

caution. These were regarded as not well suited to prescribing in the

knowledge limitations, beliefs about medication use, GPs' perceptions

context of the complex needs of the individual older patient with mul-

of older adults, older adults' perception of GPs, and fears regarding

tiple morbidities.50,60,63

deprescribing.

Delegation of tasks to other team members was mentioned,51,70
such as medication reconciliation to nurses50 or follow‐up to pharma-

3.2.1

|

The health care system

cists.57,58 In practice, this may not happen, as some GPs were uncom-

The structures and practices within the health care systems repre-

fortable

sented in the 38 included studies generated a variety of factors that

accountability and authority as a prescriber.50

with

delegation,

fearing

it

would

undermine

their

influenced both GP prescribers and older adults, and were noticeably

Disease‐specific treatment guideline use generated much concern

similar despite the variety of systems represented. These ranged from

among GPs, who thought that they promoted ongoing prescribing and

macroorganisational factors such as how care is managed and distrib-

encouraged polypharmacy.35,37,56,62,66,70 General practitioners noted

uted across multiple care providers, down to the management of indi-

that guidelines did not take into account treatment decisions in the

vidual practices, for example, regarding time management and

context of multiple morbidities or provide guidance on the appropriate

delegation of tasks.

circumstances in which to discontinue medications.37,46,47,53,56,62,64,67

Older adults often need to consult with more than one

Additionally, GPs felt unsure of the usefulness of guidelines, because

prescriber in the course of managing multiple morbidities; this may

they were based on clinical trials that rarely included older adults,

result in an increased risk of poor communication regarding medica-

especially those with multiple morbidities,37,46,56 and did not take into

tions

account outcomes valued by the patient.46

between

prescribers

34,35,38,40,46,50,56,61,62,66,67

ties.

and

confusion

about

responsibili-

General practitioners view this as a

The way guidelines were used varied among GPs, with those in the

potential barrier to enacting deprescribing. They felt that specialist

study of Sinnott et al64 prioritising the management of one disease over

prescribers regarded their treatment as a priority62,64 and focused

another, whereas those in another study62 seemed to apply guidelines

on a specific area, resulting in no one taking responsibility over-

one after another, without ranking which treatment was most essential.

all.66,67 Also, patients sometimes believed that specialists had more

Some GPs were less concerned about following guidelines when pre-

authority than GPs34,49,59 and faced confusion about which

scribing for older patients, preferring to prioritise quality of life,53,63

prescriber was responsible for, and authorised to deprescribe.49

while others thought that the use of guidelines would ensure best prac-

Conversely, GPs and older adults valued the long‐term relation-

tice.46 General practitioners were hoping for more useful tools to help

ships that they developed in the primary care context, and this worked

them rank the treatment of various diseases,67 recognise potentially
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inappropriate medications,39 or guide deprescribing of specific classes

practice, then, GPs make assessments of the potential harms or bene-

of medication.44

fits of medication based on the individual needs of their patients.53,54
Additionally, GPs lacked information about nonpharmacological

3.2.2

|

options39 and how to develop, implement, and monitor a

Older adult and GP characteristics

General practitioners' approaches to the management of their older
adults' medications varied.46,50,63 A range of characteristics influenced
this. General practitioners who had more years of clinical experience
were less likely to be concerned about adhering to clinical guidelines,
and based their decisions on their clinical reasoning skills and being
mindful of the individual needs of their older patients' overall treatment and preferences.34,56,62,64 General practitioners who had
deprescribed medications successfully in the past were more likely
to do so in the future.34,50
General practitioners ranked factors that might motivate them to
deprescribe, from most to least important and used this as a guide.
These factors included cognitive impairment, limited life expectancy,
wishes of patient or family, number of medications, and the level of
functional dependence.48 These changing clinical characteristics
encouraged GPs to consider deprescribing because they perceived that
the

risk

of

medication

continuation

exceeded

the

risk

of

deprescribing.48,50 In this context, some GPs felt more comfortable
introducing the topic of deprescribing during discussions with patients
about their quality of life versus life expectancy,62 although others
remained uncomfortable believing their patients would think they had
been given up on.48,62,64,70
Concerns about polypharmacy use in their older adult patients
were frequently raised by health care providers.34,35,40,50,53,56,62,66,67
However, their views of what constituted polypharmacy varied,50,56
and this was often assessed in an individual, case‐by‐case
manner.34,50,56 Increased pill burden or the number of medications
was a factor in triggering a medication review with a view to
deprescribing.48 Some prescribers in another study thought that
polypharmacy should be framed as a risk to patients who are aging
in the same way as they would frame a discussion about the risk of

deprescribing plan.44 Furthermore, GPs in the study by Riordan
et al60 noted that they were still influenced by pharmaceutical company salespeople, even though they perceive their information to be
biased.
An incomplete clinical picture regarding their older patients was
another knowledge limitation that negatively impacted GPs' capability
to deprescribe. This may result from patients not communicating
important information regarding their medications.35,37,50,56,61 Furthermore, other prescribers, such as medical specialists, may not effectively
communicate all their treatment plans (eg, medication indications and/
or duration of treatment) to the GP.34,35,38,40,46,48,50,51,70
Older adults had limited knowledge about their medications. The
study by Weir et al71 found that this affected their confidence to initiate deprescribing discussions. The reasons for and the potential
harms of their medications were not always known,71 or the ongoing
need for some medications was not clear.55 Patients assumed, as their
doctor had more medical knowledge than they did, that it must be
appropriate to continue their medication, otherwise, their doctor
would stop writing repeat prescriptions.59 Poor health literacy may
also be a factor that influences deprescribing decision making.41 General practitioners in Clyne et al39 earlier study thought that they may
be able to negotiate with patients to motivate them to consider
deprescribing if they could give their patients more information about
their medications.
Previous experiences of deprescribing varied, with 34% in a US
study,51 40% in a Canadian study,65 and 55% in an Australian study58
having experienced deprescribing. Knowledge of the process of
deprescribing was limited, for example, with regard to tapering dosages or trialling deprescribing59,68 or with regard to the potential
reduction in risks that deprescribing offers.45

other health problems such as stroke.34
Older adults varied in their interest for more information about
their medications and involvement in decision making.61,71 For example, raising the topic of discontinuing a medication was initiated by only
18% of older adults in a Norwegian study,68 while 55% had done so in a
US study51 and 42% in a Canadian study.69 The Canadian study found
that initiating a deprescribing conversation was more likely in older
adults who searched for information about and had an awareness of
medication harms.69 In contrast, some older adults felt fearful about
expressing their medication preferences and did not share their experience of trialling deprescribing themselves until after the fact.42,61,71

3.2.4

|

Beliefs about medication use

General practitioners generally held positive beliefs about medications.
Their previous experiences of the clinical usefulness of medications and
their belief that they generally cause few serious side effects resulted in
them favouring continued prescribing over deprescribing.37,43 This bias
towards prescribing was further promoted by the uncertain outcome of
deprescribing.34,70
In comparison, older adults hold conflicting ideas around medication use, often expressing concurrent positive and negative
beliefs.36,41 These conflicting beliefs are clearly illustrated in the 3
quantitative studies that used the Patient's Attitudes Toward

3.2.3

|

Knowledge limitations

Deprescribing survey. Reeve et al,58 Sirois et al,65 and Ng et al57 found

Knowledge limitations were commonly cited as a major barrier. Gen-

that while a majority of older adults thought that all their medications

eral practitioners reported that knowledge gaps, particularly in their

were necessary (95%, 84%, 89%, respectively), similar numbers indi-

pharmacological knowledge, negatively impacted their confidence

cated a willingness to consider deprescribing, if their doctor thought

and willingness to deprescribe.34,35,50,60,62,66 They were unsure of

it were possible (92%, 71%, 93%, respectively).

35,56,62

unsure

Older adult responses in many of the qualitative studies elaborate

of the ongoing benefit of long‐term medication use (eg, preven-

on the reasons for their conflicting beliefs. Medications were valued,

tives),43,56,62 and unsure of the outcome of deprescribing.34,37 In

as they were perceived to extend life and improve well‐being, and

the potential interactions between multiple medications,

GILLESPIE
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their use was to be expected during older age.71 Older adults were

health.55,49,71 Others remarked on the paternalistic nature of their

more likely to believe that their medications were necessary following

relationship with their GP, although they were generally accepting of

the testimony of their GP,59 recall of the usefulness of medications for

this, that it was wise not to argue, and preferred to follow their

family members and friends,71 ongoing symptom relief,36,41,71 or

doctor's advice.41,61,71 Weir et al71 compared attitudes of older adults

avoidance of preventable health issues.55 Concurrently, older adults

across 3 groups and noted that those who were frailer and/or lacked

expressed a strong dislike of using medications long‐term. They prefer

an understanding of their medications were happy to abdicate deci-

to take as few as possible.42,49,55,68,71 Sometimes, nonpharmacological

sion making about their medications, including deprescribing, to their

options were followed in order to stop medications.42 From a practical

doctor.

point of view, taking multiple medications was perceived to be a bur-

Both GPs and older adults recognised that trust could be

den by some,36,71 and notably, in the US health system, was costly.42

undermined when different prescribers gave conflicting advice about

When taking into account competing outcomes, older adults valued

deprescribing.38,49,55,62,68 Finally, others, in the study by Moen

ongoing quality of life more than extending life expectancy, suggesting

et al,55 noted a general distrust of the health system rather than of a

that, if the side effects from a particular medication were too signifi-

specific prescriber and were sceptical about the ongoing influence of

cant, they may consider discontinuing that medication.45,59

pharmaceutical companies on prescribers.

3.2.5

3.2.7

|

GP perceptions of older adults

|

Fears

General practitioner perceptions of their older patients influenced

Both older adults and GPs feared the potential for unfavourable out-

their willingness to consider raising the topic of deprescribing. General

comes from deprescribing, such as a return of symptoms, withdrawal

practitioners perceived their older patients to be generally resistant to

effects, or previously avoided serious events such as stroke, occur-

change and that they would be unlikely to accept their advice to

ring

deprescribe,

35,37,43,50,62

especially if they suggested stopping a medi-

following

the

cessation

34,37,42,50,61,62,68,70,71

tions.

of

preventative

medica-

This fear often outweighed the fear of

cation which the older adult perceived was giving them symptom

risks associated with continuing multiple, sometimes potentially inap-

relief.37 Alongside this, some believed that older adults themselves

propriate, medications from the perspective of both patients71 and

had no problem with polypharmacy.62 Explanation of potential risks

prescribers.37,64 As a result, maintaining the status quo was pre-

and uncertainties was seen as being particularly hard.47,64 General

ferred. However, older adults' fears of, or experience with, side

practitioners in the study by Schuling et al62 noted that explaining

effects,42,55,68 drug interactions when using multiple medications,

deprescribing to their older patients was made more difficult because

and/or fear of addiction,55 were factors that could influence them

of their patients' age and sometimes their poor education. Another

to consider the acceptability of deprescribing.

study, however, also of Dutch GPs, noted that some believed that

General practitioners feared that a poor outcome as a result of

even very old people were capable of entering into a shared

their deprescribing advice would undermine their relationship with

decision‐making process.53

their patient or family members62,64,70 and could lead to litiga-

General practitioners felt pressured to meet their older adults'

tion.61,62,64 Others sought to shift the responsibility for a recommen-

(and/or family members') expectations to prescribe medications,37-

dation to deprescribe, by referring to the requirements of external

39,54,56,60,70

parties such as drivers' licensing bodies.37

although some noted that with careful explanation, they

may accept the suggestion of alternative treatments.37-39 General
practitioners in the study by Wallis et al70 observed that it is important
to remember that patients are not coming to an appointment
expecting a discussion about deprescribing.

4

|

DISCUSSION

As far as we are aware, this is the first mixed studies review to consider
the factors that influence deprescribing for both community‐living older

3.2.6

Older adults' perceptions of their GP

adults and GPs. Compared to earlier reviews, the inclusion of recent

Trust was an important factor mentioned in multiple studies. Older

quantitative papers allowed us to note the strong interest of older

adults' hypothetical interest in deprescribing was associated with a

adults in deprescribing if recommended to do so by their doctor. This

higher physician trust score.57,58 However, in practice, those who

suggests that GPs' fear of patient resistance may often be unfounded.

reported higher trust were less likely to have experienced

Additionally, we noted the priority GPs give to various patient related

deprescribing.52 Older adults reported that their trust in the prescrib-

factors when considering deprescribing, including cognitive impair-

ing practices of their GP was based on the perceived clinical knowl-

ment, limited life expectancy, and patient or family preferences. Know-

edge of their GP, a belief that their GP would make decisions with

ing the original medication indication, having assistance to monitor

their best interests in mind, and on the strength of the relationship

deprescribing, and further involvement of patients in shared decision

established between themselves and their GP based on mutual

making were ranked as being the most helpful for prescribers to enable

respect, good communication, and knowledge of their prefer-

deprescribing.

|

ences.36,41,49,55,59,61,68,71 Sometimes, this level of trust meant that
61

Additionally,

we

found

that

the

factors

that

influence

Some older

deprescribing have remained unchanged over the time period covered

adults did qualify their trust, suggesting that they needed to find infor-

by the review and are similar across all of the health systems repre-

mation for themselves in order to maintain responsibility for their own

sented. This is important to note, as there has been an increase in

they did not ask for important medication information.

10 of 13

GILLESPIE

&C?JRFѥ1AGCLACѥ0CNMPRQ

ET AL.

research in this area in the last decade and this appears to have had

of the effect of medications in real‐life patients.77 Furthermore, this

little impact on primary care practice. In their systematic review of

group is excluded from most randomised control trials for the develop-

the knowledge to practice gap, Lau et al73 argue the importance of

ment of evidence‐based medicine and clinical practice guidelines.78

moving beyond the identification of barriers and facilitators, if change

Experienced GPs manage this lack of evidence by drawing on their own

is to be achieved. Most studies continue to identify barriers and

clinical knowledge base, deviating from clinical guidelines as required,

facilitators to deprescribing and examine these as separate factors,

and taking into account quality of life considerations and patient prefer-

without considering the relative importance of each of them or how

ences. This suggests that those who are less experienced may benefit

they interact.

from more structured opportunities to draw on the knowledge base of

This review of the current literature suggests that the factors that

others such as pharmacists, geriatricians, and peers, to review

influence deprescribing mostly act as barriers. Some are created by the

deprescribing decisions in the context of complex medication regimens.

health system, which provides the context for deprescribing, while

Paternalistic relationships and the asymmetry of medical knowl-

other barriers occur at the practice and individual level. At the individ-

edge undermine some older adults' confidence to discuss their prefer-

ual level, Bokhof and Junius‐Walker's24 review found that both older

ences with their GPs and/or ask questions to clarify information gaps.

adults and GPs faced uncertainty in deprescribing decision making,

This finding is similar to an earlier review on communication about

and this finding is confirmed by this review. Individual level barriers

medicines between patients and health care professionals.79 To

to deprescribing may be grouped into 2 key areas: knowledge limita-

ensure that older adults have an opportunity to make informed deci-

tions and communication gaps. Reducing uncertainty in these 2 areas,

sions, changes in medication information for patients are required to

together with addressing health system constraints, could lead to

ensure that this is accessible and understandable, irrespective of the

change in deprescribing practice.

health literacy level of the individual. This should include information
regarding how medications are deprescribed. The lack of awareness

4.1.1.

|

Health system constraints

Health system constraints, which can only be addressed at the policy
level, provide the context for any change at the practice level. Primary

of monitored deprescribing as an option is demonstrated by those
older adults who discontinued medications themselves, without
discussing their decision with their GP.

care consultations continue to be best suited to managing acute health
problems rather than chronic health conditions or multiple morbidities.74
Consultation times remain short, and reimbursement for more complex
tasks is still inadequate. These practical issues may mean GPs avoid
time‐consuming areas such as discussions about deprescribing, as they
seek to meet the needs of all their patients. As a result, deprescribing
tends to occur reactively when a significant medication related problem
arises or when there are other clear indications such as increasing cognitive impairment or limited life expectancy. However, discussing
deprescribing earlier as a routine part of medication management would
provide GPs with the opportunity to work collaboratively with the
patient, and other members of the health care team, to ensure that medication regimens remain beneficial and manageable for the patient. Several different models of integrated care, which focus on the
establishment of multidisciplinary teams or provider networks within primary care settings, have been shown to be successful in improving care
for those with chronic diseases.74 Such models could also facilitate
deprescribing and should be further researched.

4.1.3.

|

Communication gaps

The primary care model allows both the patient and their GP to
develop a relationship over time and was favoured by both parties in
the included studies. This was seen as especially important in the context of managing chronic multiple morbidities. Awareness of patient
preferences and open, shared communication in the context of trust
reduces uncertainty. The earlier reviews by Reeve et al25and Bokhof
and Junius‐Walker24 identified trust as being an important characteristic that was necessary to facilitate deprescribing, but the role of trust
may be more complex than this suggests. In some studies, trust is
associated with a willingness to consider deprescribing, suggesting
that it may facilitate acceptance of a prescriber's recommendation to
deprescribe, even in the face of uncertainty.57,58 However, other
research demonstrates that trust can also act as a barrier to
deprescribing. For example, trust was used by patients to explain
why they unquestioningly accepted their medication regimen,
resulting in lower reports of deprescribing.52 These contradictory
actions of trust were also demonstrated in the small study by Schöpf

4.1.2.

|

Knowledge limitations

et al61 included in this review and are similar to the findings regarding

General practitioners noted that they lacked pharmacological knowl-

trust in the study by Belcher et al80 of older adults' participation in

edge in the context of treating older, multimorbid adults. This suggests

medication related decision making.

that medical curricula should be revised to include more specific geriat-

Because older adults often have more than one prescriber

ric pharmacology and deprescribing education,75 together with ongoing

involved in their care, good communication structures and practices

professional development after graduation. Pharmacists, located either

within and between health care providers are especially important.

in the community or within GP practices, can also supply information.

Currently, GPs may receive little information about specialist consulta-

Those located within GP practices may be better placed to collaborate

tion outcome/s. Furthermore, GPs sometimes continued medications

and meet the immediate information needs of GPs.76

they considered inappropriate because they were not willing to chal-

The review found that the evidence available to guide GPs when

lenge their specialist counterparts, and some older adults believed that

making prescribing decisions is limited. Clinical trials rarely include older

only their specialists had the authority to deprescribe. Despite these

adults with multiple morbidities, and as a result, GPs have little evidence

challenges, GPs remain well placed to act as the overall coordinators
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of their older adults' medication regimens as they may be the only pre-

CONFLIC T OF INT E RE ST

scriber who can see the full picture of what is being taken. This sug-

The authors declare that they have no conflicts of interest.

11 of 13

gests that a collaborative approach with improved communication
between specialist and GP prescribers is needed, along with clarification of lines of responsibility.
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bers of the workforce, caregivers, and innovators, despite the challenges of the aging process.17
The review highlights that several other areas also require further
exploration. Work is required to understand the extent to which
health literacy, which is known to be lower in this age group,81 and
socio‐economic characteristics influence older adults' decisions. Additionally, research is required to further understand the complex role
of trust within long‐term doctor‐patient relationships, as it applies
to deprescribing.

4.3

|

Limitations

Our review only included studies available in English. Despite the
search methodology including multiple databases and a variety of relevant search terms, a significant number of the included studies were
identified via hand searches of reference lists of related articles and
using citation tracking. This reduces the reproducibility of our
methods. Finally, the MMAT used to assess the quality of the included
studies is still in development, so the quality scores given should be
treated cautiously.

5

|

C O N CL U S I O N

This review investigated the factors that influence deprescribing from
the perspective of both GPs and older adults aged 65 years or older
and living independently in the community. The review found that
these factors mostly act as barriers to prevent deprescribing from
entering into discussions during consultations. They have remained
static across the review period and are similar across health systems.
To achieve change, multilevel strategies should be prioritised to
address structural constraints within health systems and to manage
uncertainty at the practice and individual level, reducing knowledge
limitations and closing communication gaps.
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